MRI characterization of residual mediastinal masses in Hodgkin's disease: long-term follow-up

被引:8
作者
Di Cesare, E [1 ]
Cerone, G
Enrici, RM
Tombolini, V
Anselmo, P
Masciocchi, C
机构
[1] Univ Aquila, Dept Radiol, I-67100 Laquila, Italy
[2] Univ Roma La Sapienza, Dept Radiol, Rome, Italy
[3] Univ Roma La Sapienza, Dept Haematol, Rome, Italy
关键词
Hodgkin disease; MR; lymphoma; magnetic resonance; tissue characterization;
D O I
10.1016/j.mri.2003.08.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Our purpose was to evaluate the role of MRI in distinguishing fibrous from active residual masses in treated Hodgkin's disease. Forty patients with residual mediastinal mass larger than 1.5 cm underwent MRI 1, 3, 6, and 12 months after the end of cycles of prescribed chemotherapy or combined chemoradiotherapy. The MRI examinations were performed on a 0.5 and a 1.5 T systems, using T-1 before and after gadolinium injection and T-2-weighted sequences. Each time the residual mass was evaluated in size and signal intensity on spin echo (SE) T-2-weighted images and on SE T-1-weighted images after contrast medium. Low signal intensity and low contrast enhancement were considered signs of inactive residues; homogeneous high signal intensity and high contrast enhancement were indicative of active residual disease; heterogeneous signal intensity and heterogeneous contrast enhancement were indicative of partial remission or necrotic/inflammatory phenomena. MR showed high diagnostic accuracy in the evaluation of Hodgkin's mediastinal residues after treatment, if performed at least 6 months after the end of therapy, reaching the highest sensitivity and specificity values at 12 month follow-up (considering the three parameters-T-2 signal intensity, contrast-enhancement, and size-all together). If we consider the single parameters individually, we can observe that size variation remains the more valuable parameter to predict or to exclude a relapse. MR diagnostic accuracy at the 6-month follow-up was lower due to the higher incidence of inhomogeneous pattern. The accuracy of MR performed at 1 and at 3 months after the end of therapy was not satisfying. This represents a clinical problem because the most important clinical decisions have to be taken just in this early post-treatment phase. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 26 条
[1]   MAGNETIC-RESONANCE-IMAGING AND GA-67 SCAN IN MEDIASTINAL MALIGNANT-LYMPHOMA - A PROSPECTIVE PILOT-STUDY [J].
ABRAHAMSEN, AF ;
LIEN, HH ;
AAS, M ;
WINDEREN, M ;
HAGER, B ;
KVALOY, S ;
ELGJO, RF ;
NOME, O .
ANNALS OF ONCOLOGY, 1994, 5 (05) :433-436
[2]   Magnetic resonance imaging and Ga-67 scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: A prospective pilot study [J].
Bendini, M ;
Zuiani, C ;
Bazzocchi, M ;
Dalpiaz, G ;
Zaja, F ;
Englaro, E .
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 1996, 4 (3-4) :213-224
[3]  
Canini R, 1995, Radiol Med, V90, P448
[4]  
Capua A, 1995, Radiol Med, V90, P797
[5]   HODGKIN DISEASE - PRACTICAL CONCEPTS FOR THE DIAGNOSTIC RADIOLOGIST [J].
CASTELLINO, RA .
RADIOLOGY, 1986, 159 (02) :305-310
[6]  
CHEN JL, 1987, CANCER, V60, P407, DOI 10.1002/1097-0142(19870801)60:3<407::AID-CNCR2820600321>3.0.CO
[7]  
2-N
[8]  
Davini O, 1992, Radiol Med, V83, P230
[9]  
DRACE J, 1989, RADIOLOGY, V173, P273
[10]  
FORSGREN G, 1994, ACTA RADIOL, V35, P564